Literature DB >> 21375662

A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile.

J Crouzet1, A Sotto, E Picard, L Lachaud, N Bourgeois.   

Abstract

We describe here the first case of osteitis caused by Candida haemulonii in a young immunocompetent patient. This patient presented a history of severe peripheral vascular disease associated with a lack of hygienic conditions as the only risk factors for such an uncommon infection. Clinical signs and histological examination allowed us to determine that it was a C. haemulonii infection and not colonization. The outcome was favourable with oral voriconazole therapy and surgical revascularization. An environmental cause of such infections is most probable, as C. haemulonii has previously been isolated from different non-human sources. Identification methods, results obtained with three in vitro antifungal susceptibility methods and clinical features are reported.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375662     DOI: 10.1111/j.1469-0691.2011.03471.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.

Authors:  Xin Hou; Meng Xiao; Sharon C-A Chen; He Wang; Jing-Wei Cheng; Xin-Xin Chen; Zhi-Peng Xu; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

2.  Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.

Authors:  E Cendejas-Bueno; A Kolecka; A Alastruey-Izquierdo; B Theelen; M Groenewald; M Kostrzewa; M Cuenca-Estrella; A Gómez-López; T Boekhout
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

3.  Genome Sequence of a Multidrug-Resistant Candida haemulonii Isolate from a Patient with Chronic Leg Ulcers in Israel.

Authors:  Nancy A Chow; Lalitha Gade; Dhwani Batra; Lori A Rowe; Phalasy Juieng; Ronen Ben-Ami; Vladimir N Loparev; Anastasia P Litvintseva
Journal:  Genome Announc       Date:  2018-04-12

4.  The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes.

Authors:  Lívia S Ramos; Maria Helena G Figueiredo-Carvalho; Laura N Silva; Nahyara L M Siqueira; Joice C Lima; Samuel S Oliveira; Rodrigo Almeida-Paes; Rosely M Zancopé-Oliveira; Fabio S Azevedo; Adriana L P Ferreira; Marta H Branquinha; André L S Santos
Journal:  J Fungi (Basel)       Date:  2022-05-27

5.  First report of a clinical isolate of Candida haemulonii in Brazil.

Authors:  João Nobrega de Almeida; Adriana Lopes Motta; Flávia Rossi; Edson Abdala; Ligia Camera Pierrotti; Adriana Satie Gonçalves Kono; Maria Del Pilar Estevez Diz; Gil Benard; Gilda Maria Barbaro Del Negro
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

6.  Biofilm Formed by Candida haemulonii Species Complex: Structural Analysis and Extracellular Matrix Composition.

Authors:  Lívia S Ramos; Thaís P Mello; Marta H Branquinha; André L S Santos
Journal:  J Fungi (Basel)       Date:  2020-04-03

7.  Phenotypic Switching and Filamentation in Candida haemulonii, an Emerging Opportunistic Pathogen of Humans.

Authors:  Yuchen Deng; Shuaihu Li; Jian Bing; Wanqing Liao; Li Tao
Journal:  Microbiol Spectr       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.